Day: June 24, 2024
DALLAS, June 24, 2024 (GLOBE NEWSWIRE) — Asset Entities Inc. (“Asset Entities” or “the Company”) (NASDAQ: ASST), a provider of digital marketing and content delivery services across Discord and other social media platforms, and a Ternary payment platform company, today announced that, effective June 17, 2024, it has acquired the assets of TommyBoyTV, LLC, a company engaged in the business of Discord development, social media, online community management, marketing, and analytics.
Pursuant to the Asset Purchase Agreement, Asset Entities has paid TommyBoy $200,000 in cash as compensation for the acquired assets and entered into a consulting agreement with TommyBoy’s sole member and issued to TommyBoy’s sole member 25,000 shares of class B common stock as partial compensation for services to be rendered under the consulting agreement.
Asset...
FirstService Residential Further Enhances Market Leadership Position in California
Written by Customer Service on . Posted in Public Companies.
Acquires CitiScape Property Management Group
TORONTO, June 24, 2024 (GLOBE NEWSWIRE) — FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that FirstService Residential, the North American residential property management leader, has acquired San Francisco-based CitiScape Property Management Group, LLC (“CitiScape”). CitiScape’s existing executive team will continue to lead day-to-day operations. Terms of the transaction were not disclosed.
Founded in 1999, CitiScape is a leading full-service community association management firm in the San Francisco metropolitan market, providing a range of property management and project management services to high-rise condominium and homeowner association clients. The acquisition solidifies FirstService Residential’s market leadership in the Bay Area of Northern California.
“The...
Kura Oncology Reports Preclinical Data Supporting Potential for Menin Inhibitor in Diabetes
Written by Customer Service on . Posted in Public Companies.
– Ziftomenib induces insulin production, improves insulin sensitivity and reduces insulin resistance in preclinical model of type 2 diabetes –
– Kura advancing multiple, next-generation menin inhibitor drug candidates targeting diabetes and other metabolic diseases –
SAN DIEGO, June 24, 2024 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today reported preclinical data supporting the potential therapeutic utility of menin inhibitors in the treatment of diabetes. The new findings were presented this weekend at the American Diabetes Association’s 84th Scientific Sessions in Orlando. Copies of the presentation are available in the Posters and Presentations section on Kura’s website.
“Despite the...
Red Pine Announces Completion of Verification of Gold Assay Results Database to Support Updated Mineral Resource Estimate
Written by Customer Service on . Posted in Public Companies.
TORONTO, June 24, 2024 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company”) reports that it has completed the verification of all gold assay certificates received by the Company from 2014 to the present for the Wawa Gold Project.
Paul Martin, Interim CEO and Chair of the Board of Red Pine commented: “We are pleased to have completed the reconciliation between our drill hole database and the one built independently by WSP Global Inc. (“WSP”). This marks a critical step towards completing an updated mineral resource estimate.”
As reported in its press release of May 6, 2024, the Company engaged WSP to lead an independent data verification of all gold assay certificates from 2014 to the present. Copies of the gold assay certificates were sent directly to WSP by the two assay labs used...
Great Elm Capital Corp. (“GECC”) Raises $12 Million of Equity at Net Asset Value
Written by Customer Service on . Posted in Public Companies.
PALM BEACH GARDENS, Fla., June 24, 2024 (GLOBE NEWSWIRE) — Great Elm Capital Corp. (the “Company” or “GECC”), (NASDAQ: GECC), a business development company, today announced it issued approximately 1.0 million shares of the Company’s common stock at a current net asset value of $12.03 per share, for an aggregate gross purchase price of $12 million, to Prosper Peak Holdings, LLC (“PPH”).
Great Elm Group, Inc. (“GEG”), the parent of the Company’s investment manager, made a $3 million investment in PPH, further aligning it with shareholders.
“We have raised $38 million of non-dilutive equity year-to-date, bolstering our efforts to expand the platform,” said Matt Kaplan, GECC’s Chief Executive Officer. “Our gross net asset value by dollars has grown by nearly 80% since management and the board were refreshed in March 2022, benefiting...
Dyne Therapeutics Presents New Preclinical Data Demonstrating the Potential of the FORCE™ Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease
Written by Customer Service on . Posted in Public Companies.
WALTHAM, Mass., June 24, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced new preclinical data in a Pompe disease model demonstrating the potential of the FORCE™ platform to deliver enzyme replacement therapy to cardiac and skeletal muscle and the central nervous system (CNS). The data were presented at the New Directions in Biology and Disease of Skeletal Muscle Conference, being held June 23-26 in Fort Lauderdale, FL.
“These preclinical data show for the first time the ability of FORCE to deliver enzymes to skeletal and cardiac muscle as well as the CNS, expanding the modularity of our platform beyond oligonucleotides. The data support the...
NowVertical Group to Host Live Corporate Webinar on July 12th at 10:00 am ET
Written by Customer Service on . Posted in Public Companies.
TORONTO, June 24, 2024 (GLOBE NEWSWIRE) — NowVertical Group Inc. (TSXV: NOW) (OTCQB: NOWVF) (“NOW” or the “Company”) announces that the Company’s CEO, Sandeep Mendiratta, will be presenting an overview of the Company, including an in-depth discussion into current operations and milestones while also providing an outlook for 2024 at a corporate webinar on July 12. We invite all investors and other interested parties to register for the webinar at the link below.NowVertical Group to Host Live Corporate Webinar on July 12th at 10:00 am ETNowVertical Group’s CEO, Sandeep Mendiratta, will be hosting a webinar to provide updates on our integration strategy, share progress so far, and outline future milestones. The session will conclude with a live Q&A. You may submit your question(s) beforehand in the registration form linked...
MoneyHero Group Reports First Quarter 2024 Results
Written by Customer Service on . Posted in Public Companies.
First quarter revenue of US$22.2 million, up 24% Year-Over-Year
SINGAPORE, June 24, 2024 (GLOBE NEWSWIRE) — MoneyHero Limited (Nasdaq: MNY) (“MoneyHero” or the “Company”), a market leading personal finance and digital insurance aggregation and comparison platform in Greater Southeast Asia, today announced financial results for the quarter ended March 31, 2024.
Management Commentary:
Rohith Murthy, Chief Executive Officer, stated, “I am pleased to report another strong quarter, with revenue increasing by 24% year-over-year to $22.2 million. This significant growth underscores the effectiveness of our strategic initiatives and the robust performance across our core markets. Despite Q1 historically being a lower quarter due to the Chinese New Year holidays and the shorter month of February, which typically results in a drop from Q4...
Entrada Therapeutics Announces $100 Million Registered Direct Offering
Written by Customer Service on . Posted in Public Companies.
– The offering was led by a U.S.-based healthcare focused investor, two global mutual funds and Janus Henderson Investors, a global asset management firm –
BOSTON, June 24, 2024 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA) is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets long considered inaccessible. The Company today announced that it has entered into a securities purchase agreement with a group of investors for the purchase of 3,367,003 shares of common stock and pre-funded warrants to purchase up to 3,367,003 shares of common stock in a registered direct offering for aggregate gross proceeds of approximately $100 million. The offering was led by a U.S.-based healthcare focused investor, two global...
Elanders announces date for the report on the second quarter 2024 and conference call
Written by Customer Service on . Posted in Public Companies.
Elanders will issue its report on the second quarter 2024 on Friday 12 July, 2024, at 07:30 CET, followed by a conference call at 09:00 CET, hosted by Magnus Nilsson, President and CEO, and Åsa Vilsson, CFO.
We invite fund managers, analysts and the media to participate in the conference call.
To join, register your details using the registration link below. Once registered, you will receive a separate email containing dial in number(s) and PINs.
Register for the conference call here.
Agenda08:50 Conference number is opened 09:00 Presentation of the quarterly report 09:20 Q&A10:00 End of the conference
During the conference call a presentation will be held. To access the presentation, please use this link:
https://www.elanders.com/presentations
For further questions, please contactMagnus Nilsson, President and CEO, telephone: +46...